Follow
Erik Sjögren
Erik Sjögren
PhD Biopharmaceutics
Verified email at farmaci.uu.se
Title
Cited by
Year
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins.
A Vildhede, P Nordell, C Ahlström, AB Montaser, T Terasaki, H Lennernäs, ...
CPT: Pharmacometrics & Systems Pharmacology, 2024
2024
Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cells
O Degerstedt, P O’Callaghan, AL Clavero, J Gråsjö, O Eriksson, ...
Drug Delivery and Translational Research 14 (4), 970-983, 2024
2024
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
L Prieto Garcia, A Vildhede, P Nordell, C Ahlström, AB Montaser, ...
CPT: Pharmacometrics & Systems Pharmacology, 2024
2024
Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling
J Dong, L Prieto Garcia, Y Huang, W Tang, A Lundahl, M Elebring, ...
Clinical Pharmacology & Therapeutics 114 (4), 825-835, 2023
42023
Physiologically based pharmacokinetic modelling of rilpivirine and lenacapavir delivery by microarray patches for treatment of pediatric HIV infection
RKM Choy, J Mistilis, L Vora, FV Zanutto, AHB Sabri, I Tekko, K Moffatt, ...
7th International Conference on Microneedles 2023, 2023
2023
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans
C Tannergren, H Jadhav, E Eckernäs, J Fagerberg, P Augustijns, ...
European Journal of Pharmaceutics and Biopharmaceutics 186, 144-159, 2023
52023
Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population
LP Garcia, P Nordell, C Ahlström, H Lennernäs, E Sjögren
2023
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection …
SS Nyman, H Ahlström, AD Creusen, D Dahlgren, M Hedeland, ...
BMJ open 12 (11), e065839, 2022
22022
Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
L Prieto Garcia, A Lundahl, C Ahlström, A Vildhede, H Lennernäs, ...
CPT: Pharmacometrics & Systems Pharmacology 11 (9), 1194-1209, 2022
62022
Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds–An overview of in silico models
IR Dubbelboer, E Sjögren
International journal of pharmaceutics 621, 121808, 2022
92022
Overview of authorized drug products for subcutaneous administration: pharmaceutical, therapeutic, and physicochemical properties
IR Dubbelboer, E Sjögren
European Journal of Pharmaceutical Sciences 173, 106181, 2022
12022
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue
O Degerstedt, J Gråsjö, A Norberg, E Sjögren, P Hansson, H Lennernäs
European Journal of Pharmaceutical Sciences 172, 106150, 2022
52022
Protocol: Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose …
SS Nyman, H Ahlström, AD Creusen, D Dahlgren, M Hedeland, ...
BMJ Open 12 (11), 2022
2022
In vitro cell toxicity and intracellular uptake of doxorubicin exposed as a solution or liposomes: Implications for treatment of hepatocellular carcinoma
F Kullenberg, O Degerstedt, C Calitz, N Pavlović, D Balgoma, J Gråsjö, ...
Cells 10 (7), 1717, 2021
282021
A physiologically-based pharmacokinetic framework for prediction of drug exposure in malnourished children
E Sjögren, J Tarning, KI Barnes, EN Jonsson
Pharmaceutics 13 (2), 204, 2021
62021
Applications of physiologically based biopharmaceutics modeling (PBBM) to support drug product quality: a workshop summary report
A Mitra, S Suarez-Sharp, XJH Pepin, T Flanagan, Y Zhao, E Kotzagiorgis, ...
Journal of Pharmaceutical Sciences 110 (2), 594-609, 2021
362021
In vitro biopredictive methods: a workshop summary report
XJH Pepin, J Dressman, N Parrott, P Delvadia, A Mitra, X Zhang, ...
Journal of Pharmaceutical Sciences 110 (2), 567-583, 2021
222021
Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption (vol 22, 71, 2020)
J Eriksson, E Sjogren, H Lennernas, H Thorn
AAPS JOURNAL 23 (1), 2021
12021
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality
A Mitra, S Suarez-Sharp, XJH Pepin, T Flanagan, Y Zhao, E Kotzagiorgis, ...
2021
Correction to: Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption
J Eriksson, E Sjögren, H Lennernäs, H Thörn
The AAPS Journal 23 (1), 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20